Rouken Discovery Centre

Rouken Bio (formerly Antibody Analytics) engaged Wellwood Leslie in 2019 to undertake feasibility investigations into the redevelopment and fit out of an existing building to form their new operational headquarters.

Phase 1 was completed in in 2022 and feasibility investigations for phase 2 began immediately, resulting in a site start in 2023 for completion early 2024.

Phase 2 provided two new higher-grade laboratories which to allow the company to diversify their operations, as well as a variable configuration meeting / breakout and conference space and double the amount of staff office area and facilities. The expansion necessitated an Air Handling Unit with heap-filtration for the labs and a new substation to service the site that is sized to be suitable for phase 3 and beyond.

Feasibility investigations for phase 3 are also underway with this likely to expand over 2 floors into the remaining capacity of the building.

Location / Motherwell
Client / Rouken Bio
Status / Completed 2024
Sector / Life Sciences